Physician profile
Kanwal Singh
NPI 1184668097
$3,433.71
in general payments reported to CMS, 2019-2025
18 companies · $681 in 2025
The $681 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $109 · 2021: $124 · 2022: $207 · 2023: $788 · 2024: $1,167 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,458 · Travel and Lodging: $172 · Education: $6.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,457.53 |
| Travel and Lodging | $172.19 |
| Education | $6.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $582.65 | 2019-2025 | Repatha |
| Lilly USA, LLC | $543.16 | 2019-2025 | Mounjaro, Jardiance |
| E.R. Squibb & Sons, L.L.C. | $440.15 | 2022-2024 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $361.29 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $289.69 | 2020-2025 | Farxiga, Lokelma, Wainua |
| Abiomed | $234.04 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $220.28 | 2019-2024 | |
| Edwards Lifesciences Corporation | $149.10 | 2019 | |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Esperion Therapeutics, INC. | $97.52 | 2023 | Nexletol, Nexlizet |
| Merck Sharp & Dohme LLC | $85.98 | 2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $84.07 | 2020-2025 | Spravato, Xarelto |
| Pfizer INC. | $75.65 | 2019-2020 | |
| Medtronic, INC. | $50.61 | 2021 | |
| Boston Scientific Corporation | $26.86 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $25.71 | 2025 | Juxtapid |
| Sun Pharmaceutical Industries INC. | $22.81 | 2021 | |
| Inspire Medical Systems, INC. | $19.14 | 2024 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanwal Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.